HIV associated nephropathy pathophysiology

Jump to navigation Jump to search

HIV associated nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating HIV associated nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV associated nephropathy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV associated nephropathy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV associated nephropathy pathophysiology

CDC on HIV associated nephropathy pathophysiology

HIV associated nephropathy pathophysiology in the news

Blogs on HIV associated nephropathy pathophysiology

Directions to Hospitals Treating HIV associated nephropathy

Risk calculators and risk factors for HIV associated nephropathy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

Overview

Pathogenesis

The pathogenesis of HIV-associated nephropathy is heavily dependent upon viral, genetic, and enviornmental co factors.[1]

Viral:

HIV-1 is the strongest risk factor that is associated with the development of HIV-associated nephropathy. It has been found through murine studies, that HIV-1 infected mice expressed similar clinical and pathological characteristics to those affected by HIV-associated nephropathy.

Genetic and Enviornmental Co factors:

Genetic factors most certainly play an intricate role in disease progression. Approximately 90% of patient infected with HIV-associated nephropathy are black. This suggests a strong racial predilection for HIV-associated nephropathy. It is also important to note that through genetic tests APOL1 gene found on chromosome 22 is more commonly found in blacks than in any other race.

Environmental factors associated with HIV-associated nephropathy:


Increased risk of developing HIV
Intravenous drug use
Men having sex with men
Having more than one sexual partner


It is hypothesized that HIV-associated nephropathy is attributed to the HIV-1 virus attacking the renal epithelium, suggesting that a localized replication of the virus of the renal epithelium is needed. However, the mechanism of how the virus induces renal injure is still inconclusive. However, what is known is that in order for the virus to proliferate, the virus induces apoptosis. In various conducted studies, HIV protease (encoded in the pol gene) is found to cleave Bcl-2 and inducing apoptosis of the renal cells monkeys. However, this still not well established.[2] The role cytokines play in the mechanism of HIV-associated nephropathy is still not clearly known and is seen as non essential in HIV-associated nephropathy.[1]

Pathogenesis

  • Proviral DNA has been reported in the renal tissue of all patients with HIV-associated nephropathy (HIVAN) even in those who did not have detectable HIV-1 RNA levels in plama. [45 ).
  • HIV-1 can replicate in the kidney even in those patients who are on treatment [46]  
  • HIV-1 gene products, negative effector and viral protein r are involved.[47,48]. Zuo et al. showed that podocyte-restricted expression of negative effector or viral protein r in murine models resulted in the clinical and pathological features of HIVAN [48].  
  • Several factors are reported to contribute to the development of HIVAN such as:[49]  
    • Effects of HIV gene products
    • HIV-induced apoptosis
    • Elaboration of cytokines
  • HIV-1 infection has been reported to downregulate the expression of miRNAs in podocytes which leads to the proliferative phenotype of HIVAN [50].
  • HIV-1-infected podocytes have an increased expression of markers of proliferation, Ki-67 and cyclins and decreased expression of cyclin-dependent kinase inhibitors, suggesting that these highly differentiated cells re-enter the cell cycle [51]. Furthermore, they have persistent activation of NF-k B and increased VEGF expression increasing podocyte proliferation [52,53]. However, these proliferative cells may be of parietal rather than visceral origin, which has been demonstrated by some investigators [54]  

Genetic predisposition  

Gross Pathology

On gross pathology, kidneys in HIV-associated nephropathy have the following features:[3]

  • Pale
  • Unevenly enlarged
  • Smooth cortical surface.

Microscopic Pathology

Light Microscopy[4] Electron Microscopy[5] Immunofluorescence[6]
characteristically seen as a visceral epithelium that displays hyperplasia and hypertrophy; due a segmental or global glomerular tuft collapse. When examining the hypertrophic portions of the visceral epithelium protein droplets are seen. a glomerular basement membrane that is wrinkled and collapsed; displaying vacuoles and protein droplets hypertrophic and hyperplastic portions of the visceral epithelium, foot process effacements that are quite extensive and tubuloreticular aggregates that are present in endothelial cells. However, not all patients display tubuloreticular aggregates as the pattern is no seen in patients who express low viral loads (due to combined antiretroviral therapy). Immune deposits that show a limited nonspecific deposition (IgM and C3 in collapsed segments) or no deposits. Visceral

On microscopic pathology, kidneys in HIV-associated nephropathy have the following features:[3]

Histopathology of HIV-associated nephropathy
Light Microscopy[3] Electron Microscopy[3] Immunofluorescence[3]
  • Collapsing focal segmental glomerulosclerosis (FSGS)
  • Hypertrophied visceral epithelial cells  
  • Tubulointerstitial Injury:
    • Microcysts tubular dilation
    • Interstitial fibrosis and inflammation  
    • Wrinkling and folding of the glomerular basement membrane (GBM)
    • Hypertrophied visceral epithelial cells  
    • Visceral epithelial cells foot process effacement.  
    • Numerous tubuloreticular inclusions (TRI)
    • Nuclear bodies
  • No specific findings
  • Variable amounts of immunoglobulins and/or complement

 

References

  1. 1.0 1.1 Schwartz EJ, Klotman PE (1998). "Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy". Semin Nephrol. 18 (4): 436–45. PMID 9692355.
  2. Strack PR, Frey MW, Rizzo CJ, Cordova B, George HJ, Meade R; et al. (1996). "Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2". Proc Natl Acad Sci U S A. 93 (18): 9571–6. PMC 38469. PMID 8790371.
  3. 3.0 3.1 3.2 3.3 3.4 D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G (1989). "Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study". Kidney Int. 35 (6): 1358–70. PMID 2770114.
  4. Fogo AB, Lusco MA, Najafian B, Alpers CE (2016). "AJKD Atlas of Renal Pathology: HIV-Associated Immune Complex Kidney Disease (HIVICK)". Am J Kidney Dis. 68 (2): e9–e10. doi:10.1053/j.ajkd.2016.06.003. PMID 27477364.
  5. Fogo AB, Lusco MA, Najafian B, Alpers CE (2016). "AJKD Atlas of Renal Pathology: HIV-Associated Immune Complex Kidney Disease (HIVICK)". Am J Kidney Dis. 68 (2): e9–e10. doi:10.1053/j.ajkd.2016.06.003. PMID 27477364.
  6. Fogo AB, Lusco MA, Najafian B, Alpers CE (2016). "AJKD Atlas of Renal Pathology: HIV-Associated Immune Complex Kidney Disease (HIVICK)". Am J Kidney Dis. 68 (2): e9–e10. doi:10.1053/j.ajkd.2016.06.003. PMID 27477364.

Template:WH Template:WS